ArticleBMJ open2022

Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020.

Tobias B Polak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.